Copyright Reports & Markets. All rights reserved.

Global Small Nucleic Acid Drug Market Growth 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Small Nucleic Acid Drug Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Small Nucleic Acid Drug by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Small Nucleic Acid Drug by Country/Region, 2017, 2022 & 2028
  • 2.2 Small Nucleic Acid Drug Segment by Type
    • 2.2.1 siRNA Drug
    • 2.2.2 ASO Drug
  • 2.3 Small Nucleic Acid Drug Sales by Type
    • 2.3.1 Global Small Nucleic Acid Drug Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Small Nucleic Acid Drug Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Small Nucleic Acid Drug Sale Price by Type (2017-2022)
  • 2.4 Small Nucleic Acid Drug Segment by Application
    • 2.4.1 Duchenne Muscular Dystrophy
    • 2.4.2 Spinal Muscular Atrophy
    • 2.4.3 Cancer
    • 2.4.4 Others
  • 2.5 Small Nucleic Acid Drug Sales by Application
    • 2.5.1 Global Small Nucleic Acid Drug Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Small Nucleic Acid Drug Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Small Nucleic Acid Drug Sale Price by Application (2017-2022)

3 Global Small Nucleic Acid Drug by Company

  • 3.1 Global Small Nucleic Acid Drug Breakdown Data by Company
    • 3.1.1 Global Small Nucleic Acid Drug Annual Sales by Company (2020-2022)
    • 3.1.2 Global Small Nucleic Acid Drug Sales Market Share by Company (2020-2022)
  • 3.2 Global Small Nucleic Acid Drug Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Small Nucleic Acid Drug Revenue by Company (2020-2022)
    • 3.2.2 Global Small Nucleic Acid Drug Revenue Market Share by Company (2020-2022)
  • 3.3 Global Small Nucleic Acid Drug Sale Price by Company
  • 3.4 Key Manufacturers Small Nucleic Acid Drug Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Small Nucleic Acid Drug Product Location Distribution
    • 3.4.2 Players Small Nucleic Acid Drug Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Small Nucleic Acid Drug by Geographic Region

  • 4.1 World Historic Small Nucleic Acid Drug Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Small Nucleic Acid Drug Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Small Nucleic Acid Drug Annual Revenue by Geographic Region
  • 4.2 World Historic Small Nucleic Acid Drug Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Small Nucleic Acid Drug Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Small Nucleic Acid Drug Annual Revenue by Country/Region
  • 4.3 Americas Small Nucleic Acid Drug Sales Growth
  • 4.4 APAC Small Nucleic Acid Drug Sales Growth
  • 4.5 Europe Small Nucleic Acid Drug Sales Growth
  • 4.6 Middle East & Africa Small Nucleic Acid Drug Sales Growth

5 Americas

  • 5.1 Americas Small Nucleic Acid Drug Sales by Country
    • 5.1.1 Americas Small Nucleic Acid Drug Sales by Country (2017-2022)
    • 5.1.2 Americas Small Nucleic Acid Drug Revenue by Country (2017-2022)
  • 5.2 Americas Small Nucleic Acid Drug Sales by Type
  • 5.3 Americas Small Nucleic Acid Drug Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Small Nucleic Acid Drug Sales by Region
    • 6.1.1 APAC Small Nucleic Acid Drug Sales by Region (2017-2022)
    • 6.1.2 APAC Small Nucleic Acid Drug Revenue by Region (2017-2022)
  • 6.2 APAC Small Nucleic Acid Drug Sales by Type
  • 6.3 APAC Small Nucleic Acid Drug Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Small Nucleic Acid Drug by Country
    • 7.1.1 Europe Small Nucleic Acid Drug Sales by Country (2017-2022)
    • 7.1.2 Europe Small Nucleic Acid Drug Revenue by Country (2017-2022)
  • 7.2 Europe Small Nucleic Acid Drug Sales by Type
  • 7.3 Europe Small Nucleic Acid Drug Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Small Nucleic Acid Drug by Country
    • 8.1.1 Middle East & Africa Small Nucleic Acid Drug Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Small Nucleic Acid Drug Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Small Nucleic Acid Drug Sales by Type
  • 8.3 Middle East & Africa Small Nucleic Acid Drug Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Small Nucleic Acid Drug
  • 10.3 Manufacturing Process Analysis of Small Nucleic Acid Drug
  • 10.4 Industry Chain Structure of Small Nucleic Acid Drug

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Small Nucleic Acid Drug Distributors
  • 11.3 Small Nucleic Acid Drug Customer

12 World Forecast Review for Small Nucleic Acid Drug by Geographic Region

  • 12.1 Global Small Nucleic Acid Drug Market Size Forecast by Region
    • 12.1.1 Global Small Nucleic Acid Drug Forecast by Region (2023-2028)
    • 12.1.2 Global Small Nucleic Acid Drug Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Small Nucleic Acid Drug Forecast by Type
  • 12.7 Global Small Nucleic Acid Drug Forecast by Application

13 Key Players Analysis

  • 13.1 Ionis Pharmaceuticals
    • 13.1.1 Ionis Pharmaceuticals Company Information
    • 13.1.2 Ionis Pharmaceuticals Small Nucleic Acid Drug Product Offered
    • 13.1.3 Ionis Pharmaceuticals Small Nucleic Acid Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Ionis Pharmaceuticals Main Business Overview
    • 13.1.5 Ionis Pharmaceuticals Latest Developments
  • 13.2 Sarepta Therapeutics
    • 13.2.1 Sarepta Therapeutics Company Information
    • 13.2.2 Sarepta Therapeutics Small Nucleic Acid Drug Product Offered
    • 13.2.3 Sarepta Therapeutics Small Nucleic Acid Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Sarepta Therapeutics Main Business Overview
    • 13.2.5 Sarepta Therapeutics Latest Developments
  • 13.3 Alnylam Pharmaceuticals
    • 13.3.1 Alnylam Pharmaceuticals Company Information
    • 13.3.2 Alnylam Pharmaceuticals Small Nucleic Acid Drug Product Offered
    • 13.3.3 Alnylam Pharmaceuticals Small Nucleic Acid Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Alnylam Pharmaceuticals Main Business Overview
    • 13.3.5 Alnylam Pharmaceuticals Latest Developments
  • 13.4 Biogen
    • 13.4.1 Biogen Company Information
    • 13.4.2 Biogen Small Nucleic Acid Drug Product Offered
    • 13.4.3 Biogen Small Nucleic Acid Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Biogen Main Business Overview
    • 13.4.5 Biogen Latest Developments
  • 13.5 Nippon Shinyaku
    • 13.5.1 Nippon Shinyaku Company Information
    • 13.5.2 Nippon Shinyaku Small Nucleic Acid Drug Product Offered
    • 13.5.3 Nippon Shinyaku Small Nucleic Acid Drug Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Nippon Shinyaku Main Business Overview
    • 13.5.5 Nippon Shinyaku Latest Developments

14 Research Findings and Conclusion

The global market for Small Nucleic Acid Drug is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Small Nucleic Acid Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Small Nucleic Acid Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Small Nucleic Acid Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Small Nucleic Acid Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Small Nucleic Acid Drug players cover Ionis Pharmaceuticals, Sarepta Therapeutics, Alnylam Pharmaceuticals, Biogen and Nippon Shinyaku. etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Small Nucleic Acid Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Small Nucleic Acid Drug market, with both quantitative and qualitative data, to help readers understand how the Small Nucleic Acid Drug market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:
The study segments the Small Nucleic Acid Drug market and forecasts the market size by Type (siRNA Drug and ASO Drug,), by Application (Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Cancer and Others), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
siRNA Drug
ASO Drug

Segmentation by application
Duchenne Muscular Dystrophy
Spinal Muscular Atrophy
Cancer
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Ionis Pharmaceuticals
Sarepta Therapeutics
Alnylam Pharmaceuticals
Biogen
Nippon Shinyaku

Chapter Introduction
Chapter 1: Scope of Small Nucleic Acid Drug, Research Methodology, etc.
Chapter 2: Executive Summary, global Small Nucleic Acid Drug market size (sales and revenue) and CAGR, Small Nucleic Acid Drug market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Small Nucleic Acid Drug sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Small Nucleic Acid Drug sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Small Nucleic Acid Drug market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Ionis Pharmaceuticals, Sarepta Therapeutics, Alnylam Pharmaceuticals, Biogen and Nippon Shinyaku, etc.
Chapter 14: Research Findings and Conclusion

Buy now